비소세포 폐암 시장 점유율 분석 및 기회 [2025-2031]
Non-small Cell Lung Cancer Market Report Analysis
Non-small Cell Lung Cancer Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd
- Novartis AG
- Eli Lilly And Company
- AstraZeneca
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- ONO PHARMACEUTICAL CO., LTD.
- Boehringer Ingelheim International GmbH
Regional Overview

- 북미
- 유럽
- 아시아 태평양
- 중남미
- 중동 및 아프리카
Market Segmentation

- 선암
- 편평세포암
- 대세포암

- 베바시주맙
- 다브라페닙/트라메티닙
- 에를로티닙 염산염
- 오시머티닙 등

- 병원약국
- 소매약국
- 온라인약국 등

- 북미
- 유럽
- 아시아 태평양
- 중남미